遗传缺陷多样性解释家族性高钾性高血压的表型异质性
该回顾性研究分析153例家族性高钾性高血压患者的临床与遗传数据,发现不同基因变异(KLHL3、CUL3、WNK1、WNK4)与表型严重程度相关,CUL3和隐性KLHL3变异者病情更重且伴生长迟缓,WNK1酸性基序变异者高血压频率较低,基因筛查有助于医疗管理和遗传咨询。
要点
- CUL3和隐性KLHL3变异与严重早发型相关,常伴生长迟缓。
- WNK1酸性基序变异者高血压频率低于WNK4变异者。
- 氢氯噻嗪可改善所有组别患者的血压和高钾血症。
核心结论
- 家族性高钾性高血压的表型异质性可由不同基因缺陷解释,从CUL3和隐性KLHL3相关的严重早发型到WNK1酸性基序相关的轻型。
- 基因筛查有助于更好地指导医疗管理和遗传咨询。
研究设计与样本
- 回顾性分析153例家族性高钾性高血压患者(84例先证者,69例亲属)的临床和遗传数据。
主要发现
- 检出致病变异:KLHL3 50例、CUL3 16例、WNK1酸性基序11例、WNK4酸性基序4例、WNK1内含子1缺失3例,其中25个为新变异。
- 新发突变主要见于CUL3相关病例(12例中9例),隐性病例仅见于KLHL3相关病例(50例中14例)。
- CUL3和隐性KLHL3病例表型更严重,且与生长迟缓相关。
- WNK1酸性基序变异患者具有典型生物学表型,高血压频率低于WNK4变异者。
- 杂合KLHL3和WNK1缺失患者表型较轻;对178名亲属进行家系筛查,检出并管理69例阳性病例。
关键数值与推荐
- 所有组别中氢氯噻嗪均改善血压和高钾血症。
临床怎么用
- 对家族性高钾性高血压患者进行基因分型有助于判断表型严重程度和预后。
- 根据基因型指导遗传咨询和家系筛查。
- 氢氯噻嗪可用于改善各基因型患者的血压和高钾血症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Familial hyperkalemic hypertension is a rare inherited form of arterial hypertension. Four genes are responsible for this disease, the variants of these genes cause disruption in the regulation of ion transport in the distal renal tubule. Whether the genotype explains the large phenotypic heterogeneity has not been fully explored. METHODS: We retrospectively analyzed clinical and genetic data of 153 cases (84 probands, 69 relatives) with familial hyperkalemic hypertension. RESULTS: Pathogenic variants (25 novel variants) were identified as follows: KLHL3 (n = 50), CUL3 (n = 16), WNK1 acidic motif (n = 11), WNK4 acidic motif (n = 4) and WNK1 intron 1 deletions (n = 3). De novo cases were mainly observed in the CUL3-related cases (9 of 12) and recessive cases were only observed in KLHL3-related cases (14 of 50). More severe forms were observed in recessive KLHL3 and CUL3 cases that were also associated with growth retardation. Patients with WNK1 acidic motif variants had a typical biological phenotype and lower frequency of hypertension conversely to WNK4 variants affecting the same motif. Patients with heterozygous KLHL3 and WNK1 deletions had milder forms. Familial screening in 178 relatives allowed detection and care for 69 positive cases. Blood pressure and hyperkalemia were improved by hydrochlorothiazide in all groups. CONCLUSIONS: This study confirms the phenotypic variability ranging from the severe and early forms associated with CUL3 and recessive KLHL3 genotypes through intermediate forms associated with KLHL3 dominant, WNK4 and WNK1 deletion to mild form associated with WNK1 acidic motif genotype and reinforces the interest of genetic screening to better orientate medical care and genetic counseling.
引用
- Hureaux M, Mazurkiewicz S, Boccio V, et al. The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension. Kidney Int Rep. 2021. PMID: 34622103. doi:10.1016/j.ekir.2021.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。